Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Accenture
Chubb
Federal Trade Commission
Daiichi Sankyo
Johnson and Johnson
Citi
Fish and Richardson
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Iroko Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for IROKO PHARMS LLC, and what generic alternatives to IROKO PHARMS LLC drugs are available?

IROKO PHARMS LLC has four approved drugs.

There are twelve US patents protecting IROKO PHARMS LLC drugs on IROKO PHARMS LLC drugs in the past three years.

There are eighty-four patent family members on IROKO PHARMS LLC drugs in twenty-four countries.

Summary for Iroko Pharms Llc

International Patents:84
US Patents:12
Tradenames:4
Ingredients:3
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms LlcTIVORBEXindomethacinCAPSULE;ORAL204768-001Feb 24, 2014RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-001Oct 18, 2013RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-002Oct 18, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Iroko Pharms LlcINDOCINindomethacinCAPSULE;ORAL016059-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-002Oct 18, 2013RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Iroko Pharms LlcTIVORBEXindomethacinCAPSULE;ORAL204768-002Feb 24, 2014RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-002Oct 18, 2013RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Iroko Pharms LlcTIVORBEXindomethacinCAPSULE;ORAL204768-001Feb 24, 2014RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-002Oct 18, 2013RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Iroko Pharms LlcZORVOLEXdiclofenacCAPSULE;ORAL204592-002Oct 18, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for IROKO PHARMS LLC drugs

Drugname Dosage Strength Tradename Submissiondate
meloxicamCapsules5 mg and 10 mgVIVLODEX1/9/2017
diclofenac sodiumCapsules18 mg and 35 mgZORVOLEX6/6/2014

Non-Orange Book Patents for Iroko Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,735,450Formulation of diclofenac► Subscribe
9,522,135Formulation of indomethacin► Subscribe
9,095,496Formulation of indomethacin► Subscribe
9,808,468Formulation of meloxicam► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Iroko Pharms Llc Drugs

Country Document Number Estimated Expiration
Canada2759125► Subscribe
Singapore11201610179Q► Subscribe
BrazilPI1014272► Subscribe
South Korea101580656► Subscribe
Australia2014202776► Subscribe
Singapore175315► Subscribe
Colombia6470807► Subscribe
Philippines12016502336► Subscribe
New Zealand710383► Subscribe
Australia2010239080► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKesson
Express Scripts
Farmers Insurance
US Army
Boehringer Ingelheim
Queensland Health
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot